Inventor · disambiguated record
Martin Trudeau
Also filed as: TRUDEAU MARTIN
25 granted patents·8 pending applications·1,107 citations·filing 2001–2022
98Inventor score
Top patents by PatentIndex Score
33 records- 0198US9670163B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·44 cites·8 claims
- 0298US9139530B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·64 cites·28 claims
- 0398US8765957B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 1, 2014·73 cites·3 claims
- 0498US8754224B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 17, 2014·97 cites·18 claims
- 0597US10537565B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2018·Granted Jan 21, 2020·24 cites·26 claims
- 0697US9931334B2Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2017·Granted Apr 3, 2018·35 cites·17 claims
- 0797US9751839B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Sep 5, 2017·41 cites·3 claims
- 0897US9371287B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Jun 21, 2016·55 cites·29 claims
- 0997US8835639B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Sep 16, 2014·72 cites·28 claims
- 1097US6632809B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2001·Granted Oct 14, 2003·63 cites·26 claims
- 1197US6498178B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2001·Granted Dec 24, 2002·174 cites·45 claims
- 1296US8476442B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2010·Granted Jul 2, 2013·89 cites·13 claims
- 1396US8410274B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2012·Granted Apr 2, 2013·109 cites·22 claims
- 1494US7381827B2Processes and intermediatesVERTEX PHARMA·Filed 2005·Granted Jun 3, 2008·22 cites·18 claims
- 1594USRE40245EGyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Apr 15, 2008·36 cites·26 claims
- 1692US11291662B2Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2019·Granted Apr 5, 2022·5 cites·4 claims
- 1792US7414046B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Aug 19, 2008·35 cites·29 claims
- 1889US7652153B2Caspase inhibitors and uses thereofVERTEX PHARMA·Filed 2005·Granted Jan 26, 2010·13 cites·19 claims
- 1989US6608087B1Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2002·Granted Aug 19, 2003·29 cites·13 claims
- 2084US2023263794A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2183US7834200B2Processes and intermediatesVERTEX PHARMA·Filed 2008·Granted Nov 16, 2010·4 cites·6 claims
- 2282US7087642B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2002·Granted Aug 8, 2006·13 cites·28 claims
- 2378US8293929B2Processes and intermediatesTANOURY GERALD J·Filed 2010·Granted Oct 23, 2012·3 cites·6 claims
- 2478US7432290B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2004·Granted Oct 7, 2008·6 cites·2 claims
- 2565US2014350281A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2664US8268873B2Inhibitors of IMPDH enzymeSTAMOS DEAN·Filed 2008·Granted Sep 18, 2012·0 cites·2 claims
- 2764US6930116B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Aug 16, 2005·1 cites·6 claims
- 2864US2017327456A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 2962US2010105914A1Caspase inhibitors and uses thereofVERTEX PHARMA·Filed 2009·Application pending·0 cites
- 3061US2011064811A1Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2006·Application pending·0 cites
- 3159US2012122921A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2011·Application pending·0 cites
- 3258US2013066083A1Processes and intermediatesVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3349US2003170858A1Gyrase inhibitors and uses thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Trudeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →